- Tytuł:
- Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial
- Autorzy:
- Źródło:
- In Leukemia Research December 2021 111
Czasopismo naukowe